17 April 2019
Description FOXO4-DRI is a D-retro-inverso research peptide derived from a FOXO4 interaction motif, used in controlled in-vitro studies of proteinprotein interactions, cellular senescence pathways, and peptide structureactivity relationships under non-clinical laboratory conditions
The neuroprotective effects of N-acetylcysteine in psychiatric and neurodegenerative disorders From modulation of glutamatergic transmission to restoration of synaptic plasticity
It works for all skin types, with no serious side effects reported in studies
Long COVID Symptoms Fatigue, post-exertional malaise, brain fog Insomnia, tinnitus, vertigo, dizziness, numbness, tingling, cold or pain sensation in extremities, weakness in extremities Uncontrolled movements, awake convulsions Difficulty processing tasks/focus Short and long-term memory loss Difficulty speaking at times Headaches, migraines Loss of taste/smell, parosmia Anxiety, depression Dysautonomia/POTS Joint pain, muscle aches, fibromyalgia Night sweats, hot flashes Skin sensitivity, itching, rashes, redness Eye pressure, vision problems Menstrual changes Urinary frequency Abdominal pain, diarrhea, nausea, vomiting, bloating, food intolerances Palpitations, vertigo, arrhythmia, low blood pressure Mast Cell Activation Syndrome and Long COVID The increased inflammatory response in acute and long COVID may, in part, is mediated by mast cell activation